ERBB2 and breast carcinoma: Further sub-analyses found that early BPE changes were significantly associated with pCR in women with stage III or IV breast cancer (P = 0.019) or in patients with stage III or IV tumors that restrained to HER2-negative breast cancer (P = 0.020).